死亡后血清和心肌同质物的快速生物化学分析 - - 一项探索性研究
Niki Sarri1, Henrik Druid1,2, Ali-Reza Rezaie1
1Swedish National Board of Forensic Medicine, 17165 Solna, Sweden.
Biomolecules
|October 29, 2025
概括
分析心肌组织同质体中的心脏生物标志物,而不是血清,有助于诊断心脏突然死亡 (SCD). 这种方法,使用随时可用的分析仪,有助于病理学家识别死后早期缺血变化.
科学领域:
- 法医病理学 法医病理学
- 临床化学 临床化学
- 生物标记分析 生物标记分析
背景情况:
- 突发心脏死亡 (SCD) 的死后诊断是具有挑战性的,因为缺乏确定的标志物,如血栓.
- 传统方法与死后结构和免疫组织化学变化的缓慢发展作斗争.
- 在心肌组织和血清中探索临床化学生物标志物,以提高诊断准确度.
研究的目的:
- 调查临床化学生物标志物在心肌同质物和血清中的实用性,用于死后SCD诊断.
- 为了比较不同的提取缓冲器,用于心肌样本中的生物标志物分析.
- 评估基于组织的生物标志物与基于血清的生物标志物的诊断潜力,以区分SCD与对照.
主要方法:
- 使用各种提取缓冲器 (蒸水,T-PER,2M尿素) 分析心肌样本 (n=113) 和血清.
- 对生物标志物的测定包括AST,ALT,CK-MB,LDH,,总蛋白质,心脏Troponin T,肌球蛋白和NT-proBNP.
- 使用IndikoPlus和罗氏科巴斯8000c701分析仪进行生物标志物量化和蛋白质基因分析.
主要成果:
- 蒸水提取对大多数分析物有效,与T-PER和2M尿素相比.
- 心肌同质物中的生物标志物水平始终高于血清中的水平.
- 与对照组相比,从SCD病例的心肌样本中观察到几种生物标志物的显著损失,与血清水平不同.
结论:
- 对心肌组织同质物的分析优于血清分析,用于检测早期的死后缺血症.
- 组织同质体中选择的生物标志物可以帮助区分心脏突然死亡病例与对照病例.
- 内部的多分析仪提供快速的结果,以支持尸体解剖期间的病理决策.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
782
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
782
01:30Acute Coronary Syndrome III: Diagnostic Studies
207
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531
01:27Myocarditis II: Clinical Features and Diagnostic Tests
258
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
258